• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Email
  • Facebook
  • LinkedIn
  • Twitter
  • YouTube

International Alliance of ALS/MND Associations

  • Members' Login
  • Contact
  • Join the Alliance
  • Donate
  • Understanding ALS/MND
    • What is ALS/MND
    • Genetics
    • Diagnosis
    • Glossary
    • Navigating the Community
  • Find a Member Association
  • Support for PALS & CALS
    • Fundamental Rights for People with ALS/MND and Caregivers
    • Research
      • Voice Preservation
      • Open Science
        • Open Label Extension
      • Expanded Access
      • Understanding ALS/MND Research
      • Improving Regulatory Pathways
      • Right to Try
      • US FDA Orphan Drug Designation
      • Unproven (Off-Label) Treatments
    • Advocacy
      • Advocacy Toolkit
      • Emergency Preparedness Toolkit
      • Equitable Access to Therapies
      • Recommendations for Trial Sponsors
    • Clinical Care
      • Genetic Counselling & Testing
      • Mental Health Support
      • Nursing and Symptom Management
      • Nutrition and Swallowing
      • Occupational Therapy and Activities of Daily Living
      • Physiotherapy and Mobility
      • Respiratory Care
      • Speech Therapy and Communication
      • Support for Family & Caregivers
      • Technology
      • Global Clinic Locator
    • Drugs in Development
      • Masitinib
      • NurOwn
      • CNM-Au8
      • ILB
      • AstroRx
      • Neuronata-R / Lenzumestrocel
      • PrimeC
      • NP001
      • Pridopidine
      • SOD1 Therapies and Trials
      • C9orf72 Therapies and Trials
      • SPG302
      • Regulatory T Cell Enhancing Therapies
      • Ulefnersen
    • Approved Drugs
      • Nuedexta
      • Radicava / Edaravone
      • Riluzole / Tiglutik
      • Rozebalamin / Methylcobalamin
      • Tofersen / Qalsody
    • Drugs No Longer in Development
      • AMX0035
      • Reldesemtiv
      • Arimoclomol
      • TUDCA
      • CuATSM
  • Support for Health Professionals
    • Breaking the News in ALS/MND
    • R.A.C.E. to Diagnose ALS/MND
  • Programs & Events
    • Calendar of Events
    • Global Day Calendar
    • Alliance Meeting
    • Allied Professionals Forum
    • “Day in the Life Of” Suite
    • Alliance Webinars
    • ALS/MND Connect
    • March of Faces
    • Patient Fellows Program
    • Alliance Fellows
    • SEED Grant Program
    • International Symposium
  • About
    • Who We Are
    • ALS/MND Health Literacy Map
    • Board of Trustees
    • Councils, Forums & Committees
      • Scientific Advisory Council
      • PALS and CALS Advisory Council
      • Advocacy and Public Policy Forum
      • Research Directors Forum
      • Governance Committee
      • Finance Committee
    • Staff
    • History
    • Newsletter Archive
    • Awards
      • Forbes Norris Award
      • Humanitarian Award
      • Allied Health Professional Award
      • Student Innovation Award
  • Members
    • Member Registration
    • Forgot Password

Admin

  • Profile
  • Topics Started
  • Replies Created
  • Engagements
  • Favorites

Topics Engaged In

Viewing topic 1 (of 1 total)
    • Topic
    • Voices
    • Posts
    • Last Post
    • Forum Guidelines

      Started by: Admin in: Member Forum

    • 1
    • 1
    • 10 years, 1 month ago

      Admin

  •  

Viewing topic 1 (of 1 total)

Primary Sidebar

Advocacy

  • Advocacy Toolkit

Approved Drugs

  • Nuedexta
  • Radicava/Edaravone
  • Riluzole/Tiglutik
  • Rozebalamin / Methylcobalamin
  • Tofersen/Qalsody

Drugs in Development

  • AB Science – Masitinib
  • NurOwn
  • Clene Nanomedicine – CNM-Au8
  • ILB
  • Kadimastem – AstroRx
  • Neuronata-R / Lenzumestrocel
  • NeuroSense – PrimeC
  • NP001
  • Prilenia Therapeutics – Pridopidine
  • SOD1 Therapies & Trials
  • SPG302
  • Regulatory T Cell Enhancing Therapies
  • Ulefnersen

Care services

  • Genetic Counselling & Testing
  • Mental Health Support
  • Nursing and Symptom Management
  • Nutrition and Swallowing
  • Occupational Therapy and Activities of Daily Living
  • Physiotherapy and Mobility
  • Respiratory Care
  • Speech Therapy and Communication
  • Support for Family & Caregivers
  • Technology

Support for members

  • Alliance Support Grant
  • About the meetings

Events/Programs

  • Calendar of Events/Programs
  • Alliance Webinars
  • Alliance Meeting
  • Allied Professionals Forum
  • ALS/MND Connect
  • Global Day Calendar
  • March of Faces
  • International Symposium

About

  • Who We Are
  • Board of Trustees
  • Councils, Forums & Committees
    • PALS and CALS Advisory Council
    • Scientific Advisory Council
    • Advocacy and Public Policy Forum
    • Research Directors Forum
    • Governance Committee
    • Finance Committee
  • Staff
  • History
  • Newsletter Archive
    • Newsletters
    • Meetings
  • Awards

Upcoming Events

Sep 22
2:00 pm - 3:00 pm EDT

ALS Association Webinar: Affordable Tools for Everyday Independence

Sep 24
1:00 pm - 2:00 pm EDT

Les Turner ALS Foundation: Cognitive and Language Impairments in ALS & ALS-FTD

Oct 13
8:00 am - 9:00 am EDT

Member Forum: Technology Solutions for PALS

Oct 13
6:00 pm - 7:00 pm EDT

Member Forum: Technology Solutions for PALS

Oct 15
9:00 am - 10:00 am EDT

Webinar: The Use of AI in ALS/MND

View Calendar

  • Jean

    Jean
    jean

  • Ywan Dierick, Belgium

    Ywan Dierick, Belgium

  • Den Haag, Netherlands

    Den Haag, Netherlands

  • Elkin Gaviria, Colombia

    Elkin Gaviria, Colombia

  • Soledad Rodriguez, Spain

    Soledad Rodriguez, Spain

  • Bob Simonds, USA

    Bob Simonds, USA

  • Animesh Kumar, India

    Animesh Kumar, India

  • Murat Morali, Turkey

    Murat Morali, Turkey

  • Leon Ryba, Argentina

    Leon Ryba, Argentina

  • Fabio Carvalho, Brazil

    Fabio Carvalho, Brazil

  • Jon Newsome, USA

    Jon Newsome, USA

  • Ismail Gokcek, Turkey

    Ismail Gokcek, Turkey
    ismail_gokcek_alsmnd_tr

  • Shay Rishoni, Israel

    Shay Rishoni, Israel

  • Diana Fernandez, Argentina

    Diana Fernandez, Argentina

  • Greg Heydet, USA

    Greg Heydet, USA

  • Sébastien Batiot, France

    Sébastien Batiot, France

  • Paul Launer, USA

    Paul Launer, USA

  • Mike Small, UK

    Mike Small, UK

  • Semra Gokalp, Turkey

    Semra Gokalp, Turkey

  • Dawn Morton, Scotland

    Dawn Morton, Scotland

  • Sharon Corosanite, USA

    Sharon Corosanite, USA

  • Maurice LeClerc, Canada

    Maurice LeClerc, Canada

  • Cliff Marshman, USA

    Cliff Marshman, USA
    CliffMarshman

  • Fabio Correia, Brazil

    Fabio Correia, Brazil

  • Bayley, Australia

    Bayley, Australia

  • Roy Taylor, Ireland

    Roy Taylor, Ireland
    roy

  • Timothy Holman, Switzerland

    Timothy Holman, Switzerland

  • Ana Lilia Rodriguez, Mexico

    Ana Lilia Rodriguez, Mexico

  • Steven Gallagher, Canada

    Steven Gallagher, Canada

  • Susan Keldani, USA

    Susan Keldani, USA

  • Graham Johnson, Australia

    Graham Johnson, Australia

  • Ian Roberts, Australia

    Ian Roberts, Australia

  • Rudiger Hanemann, Germany

    Rudiger Hanemann, Germany

  • Lee Millard, England

    Lee Millard, England

  • Philip Brindle, England

    Philip Brindle, England

  • Shaleen Latchman, Canada

    Shaleen Latchman, Canada

  • Angela Jansen, Germany

    Angela Jansen, Germany

  • Anthony Lynch, Australia

    Anthony Lynch, Australia

  • Steve

    Steve

  • Malu Araujo Ribeiro, Brazil

    Malu Araujo Ribeiro, Brazil

  • Juvenal Bayona Romero, Colombia

    Juvenal Bayona Romero, Colombia

  • Mark Miller, UK

    Mark Miller, UK

  • Claudette Sturk, Canada

    Claudette Sturk, Canada
    Picture2

  • Hollister

    Hollister
    hollister

  • Angie Bordaen, Belgium

    Angie Bordaen, Belgium

  • Chirag Walia, India

    Chirag Walia, India
    ChiragWalia

  • Zelina Brito, Brazil

    Zelina Brito, Brazil

  • Joyce Rusinak, USA

    Joyce Rusinak, USA

  • Ana María Zavala, Mexico

    Ana María Zavala, Mexico

  • Claudia Cominetti, Italy

    Claudia Cominetti, Italy

Learn more about the March of Faces

Coronavirus (COVID-19) Resources

Instructions

First-time users, please register by clicking the register button below this log in form. You will then be able to create a user name and password. Only Alliance members are eligible to register.

If you have already registered, please use the details provided to log in using this form.

Drugs No Longer in Development

  • AMX0035
  • Reldesemtiv
  • Arimoclomol
  • TUDCA

Footer

Stay connected to the global ALS/MND community.

Subscribe to receive our newsletter and updates on how to get involved across the Alliance network.

 
This field is for validation purposes and should be left unchanged.
  • Email
  • Facebook
  • LinkedIn
  • Twitter
  • YouTube
Return to top of page

Contact | Disclaimer | Privacy Notice & Cookies | Sitemap

Copyright © 2026 The International Alliance of ALS/MND Associations. All rights reserved.


Registered in England: Charity Number 1079504 · Site built by graphics.coop · Powered by WordPress · Members' login